Search - tctmd.com

Displaying 41 - 60 of 141

Sort: Relevancy | Date

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

Presentation ACC 2022

The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF

Presenter: Michael Felker

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Todd Neale

April 03, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

News Conference News ACC 2021

Cooling OHCA Patients to 31°C Not Superior to 34°C: CAPITAL-CHILL

Caitlin E. Cox

May 26, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

Todd Neale

May 20, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

Advertisement

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Cooling OHCA Patients to 31°C Not Superior to 34°C: CAPITAL-CHILL

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

New STRENGTH Analysis Revives Omega-3 Debate

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content